A study published this Tuesday in the scientific journal The Lancet indicates that the monkey pox could be “withering” for those people who suffer HIV advanced and low defenses.
Made in the Germans Trais i Pujo Hospitalin Barcelona; the study analyzes 382 cases of monkeypox in patients with HIVMostly men. The investigation showed that mortality reaches 15% of cases, presenting, in addition, more severe symptoms.
Oriol Mitja, a doctor and participant in the research, commented that “some of these kids asked for sedation because they said they couldn’t take the pain anymore. The injuries are equivalent to those of a major burn.” The usual symptoms usually include mild vesicles, which disappear within a few weeks, but these patients apparently presented skin ulcers that did not reduce and even spread to the eyes, lung area and intestines.
The outbreak of monkeypox, renamed mpox by the World Health Organizationbegan in May 2022 and some 85,000 cases are currently registered.
He also added that the groups most at risk are people living with the virus HIV and who take daily antiretroviral drugs. As the researchers explain, the HIV destroys CD4 lymphocytes, white blood cells responsible for protecting people against infections. The cases of monkeypox under study, identified in men with HIV advanced, a threshold below 200 lymphocytes per cubic millimeter of blood. The norm, in adults/adolescents, is usually between 500 and 1200.
With these values, the second virus that affects them, mpox, is “withering” according to Oriol Mitja: “We don’t call it withering because of its speed, but because it doesn’t stop. Go on and on and on. No matter how many interventions you make, the virus continues to progress.”
The researchers say it is not a new variant of monkeypox, but the same pathogen causes a different disease in people with HIV.
The authors of the research urge the World Health Organization to include mpox or “monkey pox” in the list of deadly HIV/AIDS diseases. Currently, there are 14 registered infections that can be dangerous for people with advanced HIV.
the british doctor Chole Orkinco-author of the research, recommended that “every person with mpox should be tested for HIV. And all the people with HIV and mpox should take a test to measure their defenses.
BF / ED
You may also like